TreeWAS – Variant ID: rs4149263

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K51 Ulcerative colitis	0.000	0.962	0.038
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.962	0.038
C64 Malignant neoplasm of kidney, except renal pelvis	0.036	0.964	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.964	0.036
K51.9 Ulcerative colitis, unspecified	0.000	0.966	0.034
K51.4 Pseudopolyposis of colon	0.000	0.966	0.034
K51.5 Mucosal proctocolitis	0.000	0.970	0.030
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.971	0.029
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.972	0.028
K51.8 Other ulcerative colitis	0.000	0.978	0.022
T36-T50 Poisoning by drugs, medicaments and biological substances	0.020	0.980	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.019	0.981	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.019	0.981	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.019	0.981	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.018	0.982	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.018	0.982	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.017	0.983	0.000
T36 Poisoning by systemic antibiotics	0.017	0.983	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.017	0.983	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.017	0.983	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.017	0.983	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.017	0.983	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.016	0.984	0.000
C64-C68 Malignant neoplasms of urinary tract	0.016	0.984	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.016	0.984	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.016	0.984	0.000
T36.0 Penicillins	0.015	0.985	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.015	0.985	0.000
T40.2 Other opioids	0.015	0.985	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.015	0.985	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.015	0.985	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.015	0.985	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.015	0.985	0.000
T46.1 Calcium-channel blockers	0.014	0.986	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.014	0.986	0.000
T38.1 Thyroid hormones and substitutes	0.014	0.986	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.014	0.986	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.014	0.986	0.000
T45.2 Vitamins, not elsewhere classified	0.014	0.986	0.000
T50.4 Drugs affecting uric acid metabolism	0.014	0.986	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.014	0.986	0.000
T38.9 Other and unspecified hormone antagonists	0.014	0.986	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.014	0.986	0.000
T38.7 Androgens and anabolic congeners	0.014	0.986	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.014	0.986	0.000
T38.5 Other oestrogens and progestogens	0.014	0.986	0.000
T38.4 Oral contraceptives	0.014	0.986	0.000
T38.2 Antithyroid drugs	0.014	0.986	0.000
T38.0 Glucocorticoids and synthetic analogues	0.014	0.986	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.014	0.986	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.014	0.986	0.000
T46.7 Peripheral vasodilators	0.014	0.986	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.014	0.986	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.014	0.986	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.014	0.986	0.000
T43.9 Psychotropic drug, unspecified	0.013	0.986	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.013	0.986	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.986	0.000
C65 Malignant neoplasm of renal pelvis	0.014	0.986	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.013	0.986	0.000
T45.0 Antiallergic and antiemetic drugs	0.013	0.987	0.000
Z50.0 Cardiac rehabilitation	0.013	0.987	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.013	0.987	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.013	0.987	0.000
C66 Malignant neoplasm of ureter	0.013	0.987	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.013	0.987	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.013	0.987	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.013	0.987	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.013	0.987	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.013	0.987	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.013	0.987	0.000
T44.0 Anticholinesterase agents	0.013	0.987	0.000
T36.9 Systemic antibiotic, unspecified	0.012	0.987	0.000
T36.8 Other systemic antibiotics	0.012	0.987	0.000
T36.7 Antifungal antibiotics, systemically used	0.012	0.987	0.000
T36.6 Rifamycins	0.012	0.987	0.000
T36.5 Aminoglycosides	0.012	0.987	0.000
T36.4 Tetracyclines	0.012	0.987	0.000
T36.3 Macrolides	0.012	0.987	0.000
T36.2 Chloramphenicol group	0.012	0.987	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.012	0.987	0.000
T43.6 Psychostimulants with abuse potential	0.012	0.987	0.000
T50.8 Diagnostic agents	0.012	0.987	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.012	0.988	0.000
T40.8 Lysergide [LSD]	0.012	0.988	0.000
T40.7 Cannabis (derivatives)	0.012	0.988	0.000
T40.5 Cocaine	0.012	0.988	0.000
T40.3 Methadone	0.012	0.988	0.000
T40.1 Heroin	0.012	0.988	0.000
T40.0 Opium	0.012	0.988	0.000
T40.6 Other and unspecified narcotics	0.012	0.988	0.000
T50.7 Analeptics and opioid receptor antagonists	0.012	0.988	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.012	0.988	0.000
T50.5 Appetite depressants	0.012	0.988	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.012	0.988	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.012	0.988	0.000
T50.1 Loop [high-ceiling] diuretics	0.012	0.988	0.000
T50.0 Mineralocorticoids and their antagonists	0.012	0.988	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.988	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.012	0.988	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.012	0.988	0.000
T45.8 Other primarily systemic and haematological agents	0.012	0.988	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.012	0.988	0.000
T45.6 Fibrinolysis-affecting drugs	0.012	0.988	0.000
T45.4 Iron and its compounds	0.012	0.988	0.000
T45.3 Enzymes, not elsewhere classified	0.012	0.988	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.012	0.988	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.012	0.988	0.000
T47.7 Emetics	0.012	0.988	0.000
T47.6 Antidiarrhoeal drugs	0.012	0.988	0.000
T47.5 Digestants	0.012	0.988	0.000
T47.4 Other laxatives	0.012	0.988	0.000
T47.3 Saline and osmotic laxatives	0.012	0.988	0.000
T47.2 Stimulant laxatives	0.012	0.988	0.000
T47.0 Histamine H(2)-receptor antagonists	0.012	0.988	0.000
T40.4 Other synthetic narcotics	0.012	0.988	0.000
T42.4 Benzodiazepines	0.012	0.988	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.011	0.989	0.000
T37.5 Antiviral drugs	0.011	0.989	0.000
T37.4 Anthelminthics	0.011	0.989	0.000
T37.3 Other antiprotozoal drugs	0.011	0.989	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.011	0.989	0.000
T37.1 Antimycobacterial drugs	0.011	0.989	0.000
T37.0 Sulphonamides	0.011	0.989	0.000
T41.5 Therapeutic gases	0.011	0.989	0.000
T41.4 Anaesthetic, unspecified	0.011	0.989	0.000
T41.3 Local anaesthetics	0.011	0.989	0.000
T41.2 Other and unspecified general anaesthetics	0.011	0.989	0.000
T41.1 Intravenous anaesthetics	0.011	0.989	0.000
T41.0 Inhaled anaesthetics	0.011	0.989	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.011	0.989	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.011	0.989	0.000
T48.5 Anti-common-cold drugs	0.011	0.989	0.000
T48.4 Expectorants	0.011	0.989	0.000
T48.3 Antitussives	0.011	0.989	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.011	0.989	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.011	0.989	0.000
T48.0 Oxytocic drugs	0.011	0.989	0.000
T49.9 Topical agent, unspecified	0.011	0.989	0.000
T49.8 Other topical agents	0.011	0.989	0.000
T49.7 Dental drugs, topically applied	0.011	0.989	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.011	0.989	0.000
T49.5 Ophthalmological drugs and preparations	0.011	0.989	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.011	0.989	0.000
T49.3 Emollients, demulcents and protectants	0.011	0.989	0.000
T49.2 Local astringents and local detergents	0.011	0.989	0.000
T49.1 Antipruritics	0.011	0.989	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.011	0.989	0.000
T45.5 Anticoagulants	0.010	0.989	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.010	0.989	0.000
T42.3 Barbiturates	0.010	0.989	0.000
T42.2 Succinimides and oxazolidinediones	0.010	0.989	0.000
C68.0 Urethra	0.010	0.990	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.010	0.990	0.000
H40.1 Primary open-angle glaucoma	0.000	0.990	0.010
T43.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.990	0.000
H52.3 Anisometropia and aniseikonia	0.000	0.991	0.009
C68.9 Urinary organ, unspecified	0.009	0.991	0.000
C68.8 Overlapping lesion of urinary organs	0.009	0.991	0.000
C68.1 Paraurethral glands	0.009	0.991	0.000
T42.1 Iminostilbenes	0.009	0.991	0.000
F60 Specific personality disorders	0.009	0.991	0.000
F60.9 Personality disorder, unspecified	0.009	0.991	0.000
F60.3 Emotionally unstable personality disorder	0.008	0.992	0.000
T42.0 Hydantoin derivatives	0.008	0.992	0.000
H40 Glaucoma	0.000	0.992	0.008
F60.7 Dependent personality disorder	0.008	0.992	0.000
T39.0 Salicylates	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
H40.0 Glaucoma suspect	0.000	0.992	0.008
T39.1 4-Aminophenol derivatives	0.007	0.993	0.000
T39.4 Antirheumatics, not elsewhere classified	0.007	0.993	0.000
T39.2 Pyrazolone derivatives	0.007	0.993	0.000
F60.0 Paranoid personality disorder	0.007	0.993	0.000
F60.8 Other specific personality disorders	0.007	0.993	0.000
F60.5 Anankastic personality disorder	0.007	0.993	0.000
H40.2 Primary angle-closure glaucoma	0.000	0.993	0.007
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.007	0.993	0.000
F60.6 Anxious [avoidant] personality disorder	0.007	0.993	0.000
H52.0 Hypermetropia	0.000	0.993	0.007
F60.4 Histrionic personality disorder	0.007	0.993	0.000
F60.2 Dissocial personality disorder	0.007	0.993	0.000
F60.1 Schizoid personality disorder	0.007	0.993	0.000
F60-F69 Disorders of adult personality and behaviour	0.007	0.993	0.000
H40.5 Glaucoma secondary to other eye disorders	0.000	0.993	0.007
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.006	0.993	0.000
H52 Disorders of refraction and accommodation	0.000	0.993	0.007
H40.4 Glaucoma secondary to eye inflammation	0.000	0.993	0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
U89.8 Agent resistant to other single specified antibiotic	0.006	0.994	0.000
F22.0 Delusional disorder	0.006	0.994	0.000
H40.6 Glaucoma secondary to drugs	0.000	0.994	0.006
H40.3 Glaucoma secondary to eye trauma	0.000	0.994	0.006
C67 Malignant neoplasm of bladder	0.006	0.994	0.000
H40.8 Other glaucoma	0.000	0.994	0.006
F22 Persistent delusional disorders	0.006	0.994	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.006	0.994	0.000
H52.7 Disorder of refraction, unspecified	0.000	0.994	0.006
C67.3 Anterior wall of bladder	0.006	0.994	0.000
C71.9 Brain, unspecified	0.000	0.994	0.006
H71 Cholesteatoma of middle ear	0.000	0.994	0.006
F10.4 Withdrawal state with delirium	0.006	0.994	0.000
Z73.9 Problem related to life-management difficulty, unspecified	0.006	0.994	0.000
Chapter V Mental and behavioural disorders	0.006	0.994	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.005	0.994	0.000
F20 Schizophrenia	0.005	0.995	0.000
H65.3 Chronic mucoid otitis media	0.000	0.995	0.005
B37.8 Candidiasis of other sites	0.005	0.995	0.000
C67.4 Posterior wall of bladder	0.005	0.995	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.005	0.995	0.000
F68 Other disorders of adult personality and behaviour	0.005	0.995	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.005	0.995	0.000
F65 Disorders of sexual preference	0.005	0.995	0.000
F63 Habit and impulse disorders	0.005	0.995	0.000
F61 Mixed and other personality disorders	0.005	0.995	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.005	0.995	0.000
C91.0 Acute lymphoblastic leukaemia	0.005	0.995	0.000
C91.4 Hairy-cell leukaemia	0.005	0.995	0.000
H52.6 Other disorders of refraction	0.000	0.995	0.005
H52.5 Disorders of accommodation	0.000	0.995	0.005
H52.4 Presbyopia	0.000	0.995	0.005
F00-F09 Organic, including symptomatic, mental disorders	0.005	0.995	0.000
C67.6 Ureteric orifice	0.005	0.995	0.000
F69 Unspecified disorder of adult personality and behaviour	0.005	0.995	0.000
B44 Aspergillosis	0.005	0.995	0.000
F10.5 Psychotic disorder	0.005	0.995	0.000
B35 Dermatophytosis	0.005	0.995	0.000
C91 Lymphoid leukaemia	0.005	0.995	0.000
F00 Dementia in Alzheimer's disease	0.005	0.995	0.000
F20.9 Schizophrenia, unspecified	0.005	0.995	0.000
F29 Unspecified nonorganic psychosis	0.005	0.995	0.000
F03 Unspecified dementia	0.005	0.995	0.000
F23 Acute and transient psychotic disorders	0.005	0.995	0.000
C67.7 Urachus	0.005	0.995	0.000
F10.0 Acute intoxication	0.005	0.995	0.000
B35.3 Tinea pedis	0.005	0.995	0.000
B44.9 Aspergillosis, unspecified	0.005	0.995	0.000
F20.0 Paranoid schizophrenia	0.005	0.995	0.000
C91.1 Chronic lymphocytic leukaemia	0.005	0.995	0.000
F99-F99 Unspecified mental disorder	0.005	0.995	0.000
F64 Gender identity disorders	0.004	0.995	0.000
F22.9 Persistent delusional disorder, unspecified	0.004	0.995	0.000
F22.8 Other persistent delusional disorders	0.004	0.995	0.000
C67.5 Bladder neck	0.005	0.995	0.000
F10.6 Amnesic syndrome	0.004	0.995	0.000
F28 Other nonorganic psychotic disorders	0.004	0.995	0.000
F24 Induced delusional disorder	0.004	0.995	0.000
F21 Schizotypal disorder	0.004	0.995	0.000
C67.1 Dome of bladder	0.004	0.995	0.000
H52.2 Astigmatism	0.000	0.995	0.004
F62.9 Enduring personality change, unspecified	0.004	0.995	0.000
H65 Nonsuppurative otitis media	0.000	0.996	0.004
B35-B49 Mycoses	0.004	0.996	0.000
F11 Mental and behavioural disorders due to use of opioids	0.004	0.996	0.000
F10.2 Dependence syndrome	0.004	0.996	0.000
B44.8 Other forms of aspergillosis	0.004	0.996	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.004	0.996	0.000
B37 Candidiasis	0.004	0.996	0.000
B44.1 Other pulmonary aspergillosis	0.004	0.996	0.000
B37.1 Pulmonary candidiasis	0.004	0.996	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.004	0.996	0.000
B35.1 Tinea unguium	0.004	0.996	0.000
F20.5 Residual schizophrenia	0.004	0.996	0.000
F62.8 Other enduring personality changes	0.004	0.996	0.000
F62.1 Enduring personality change after psychiatric illness	0.004	0.996	0.000
F62.0 Enduring personality change after catastrophic experience	0.004	0.996	0.000
F70-F79 Mental retardation	0.004	0.996	0.000
F20.8 Other schizophrenia	0.004	0.996	0.000
F20.6 Simple schizophrenia	0.004	0.996	0.000
F20.4 Postschizophrenic depression	0.004	0.996	0.000
F20.3 Undifferentiated schizophrenia	0.004	0.996	0.000
F20.2 Catatonic schizophrenia	0.004	0.996	0.000
F20.1 Hebephrenic schizophrenia	0.004	0.996	0.000
H40.9 Glaucoma, unspecified	0.000	0.996	0.004
B35.6 Tinea cruris	0.004	0.996	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.004	0.996	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.004	0.996	0.000
F80-F89 Disorders of psychological development	0.004	0.996	0.000
F10.8 Other mental and behavioural disorders	0.004	0.996	0.000
F10.7 Residual and late-onset psychotic disorder	0.004	0.996	0.000
F63.9 Habit and impulse disorder, unspecified	0.004	0.996	0.000
F63.8 Other habit and impulse disorders	0.004	0.996	0.000
F63.3 Trichotillomania	0.004	0.996	0.000
F63.2 Pathological stealing [kleptomania]	0.004	0.996	0.000
F63.1 Pathological fire-setting [pyromania]	0.004	0.996	0.000
F63.0 Pathological gambling	0.004	0.996	0.000
F65.9 Disorder of sexual preference, unspecified	0.004	0.996	0.000
F65.8 Other disorders of sexual preference	0.004	0.996	0.000
F65.6 Multiple disorders of sexual preference	0.004	0.996	0.000
F65.5 Sadomasochism	0.004	0.996	0.000
F65.4 Paedophilia	0.004	0.996	0.000
F65.3 Voyeurism	0.004	0.996	0.000
F65.2 Exhibitionism	0.004	0.996	0.000
F65.1 Fetishistic transvestism	0.004	0.996	0.000
F65.0 Fetishism	0.004	0.996	0.000
F66.9 Psychosexual development disorder, unspecified	0.004	0.996	0.000
F66.8 Other psychosexual development disorders	0.004	0.996	0.000
F66.2 Sexual relationship disorder	0.004	0.996	0.000
F66.1 Egodystonic sexual orientation	0.004	0.996	0.000
F66.0 Sexual maturation disorder	0.004	0.996	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.004	0.996	0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.004	0.996	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.004	0.996	0.000
F99 Mental disorder, not otherwise specified	0.004	0.996	0.000
Z90.5 Acquired absence of kidney	0.004	0.996	0.000
H40-H42 Glaucoma	0.000	0.996	0.004
F02 Dementia in other diseases classified elsewhere	0.004	0.996	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.004	0.996	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.004	0.996	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.004	0.996	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.004	0.996	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.004	0.996	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.004	0.996	0.000
H46 Optic neuritis	0.000	0.996	0.004
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.004	0.996	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.004	0.996	0.000
C91.5 Adult T-cell leukaemia	0.004	0.996	0.000
F09 Unspecified organic or symptomatic mental disorder	0.004	0.996	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.004	0.996	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.004	0.996	0.000
C71 Malignant neoplasm of brain	0.000	0.996	0.004
B44.7 Disseminated aspergillosis	0.004	0.996	0.000
B44.2 Tonsillar aspergillosis	0.004	0.996	0.000
B44.0 Invasive pulmonary aspergillosis	0.004	0.996	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.996	0.004
B37.4 Candidiasis of other urogenital sites	0.004	0.996	0.000
C71.8 Overlapping lesion of brain	0.000	0.996	0.004
H73 Other disorders of tympanic membrane	0.000	0.996	0.004
U89 Agent resistant to other and unspecified antibiotics	0.004	0.996	0.000
B35.9 Dermatophytosis, unspecified	0.004	0.996	0.000
B35.8 Other dermatophytoses	0.004	0.996	0.000
B35.5 Tinea imbricata	0.004	0.996	0.000
B35.4 Tinea corporis	0.004	0.996	0.000
B35.2 Tinea manuum	0.004	0.996	0.000
B35.0 Tinea barbae and tinea capitis	0.004	0.996	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.004	0.996	0.000
C91.7 Other lymphoid leukaemia	0.004	0.996	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.004	0.996	0.000
C91.3 Prolymphocytic leukaemia	0.004	0.996	0.000
C91.2 Subacute lymphocytic leukaemia	0.004	0.996	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.004	0.996	0.000
C91.9 Lymphoid leukaemia, unspecified	0.004	0.996	0.000
F23.8 Other acute and transient psychotic disorders	0.003	0.996	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.003	0.996	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.003	0.996	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.003	0.996	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.004	0.996	0.000
C67.0 Trigone of bladder	0.003	0.996	0.000
N18.5 Chronic kidney disease, stage 5	0.004	0.996	0.000
F11.2 Dependence syndrome	0.004	0.996	0.000
H65.2 Chronic serous otitis media	0.000	0.996	0.004
N18.0 End-stage renal disease	0.004	0.996	0.000
B49 Unspecified mycosis	0.004	0.996	0.000
B37.7 Candidal septicaemia	0.004	0.996	0.000
C67.8 Overlapping lesion of bladder	0.003	0.996	0.000
F64.9 Gender identity disorder, unspecified	0.003	0.996	0.000
F64.8 Other gender identity disorders	0.003	0.996	0.000
F64.2 Gender identity disorder of childhood	0.003	0.996	0.000
F64.1 Dual-role transvestism	0.003	0.996	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.996	0.004
F10.9 Unspecified mental and behavioural disorder	0.003	0.996	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.003	0.996	0.000
Z73 Problems related to life-management difficulty	0.004	0.996	0.000
C67.2 Lateral wall of bladder	0.003	0.996	0.000
H65-H75 Diseases of middle ear and mastoid	0.000	0.996	0.004
F11.1 Harmful use	0.003	0.997	0.000
F01 Vascular dementia	0.003	0.997	0.000
H65.1 Other acute nonsuppurative otitis media	0.000	0.997	0.003
H65.0 Acute serous otitis media	0.000	0.997	0.003
Z73.3 Stress, not elsewhere classified	0.003	0.997	0.000
B48 Other mycoses, not elsewhere classified	0.003	0.997	0.000
B47 Mycetoma	0.003	0.997	0.000
B46 Zygomycosis	0.003	0.997	0.000
B45 Cryptococcosis	0.003	0.997	0.000
B43 Chromomycosis and phaeomycotic abscess	0.003	0.997	0.000
B42 Sporotrichosis	0.003	0.997	0.000
B41 Paracoccidioidomycosis	0.003	0.997	0.000
B40 Blastomycosis	0.003	0.997	0.000
B39 Histoplasmosis	0.003	0.997	0.000
B38 Coccidioidomycosis	0.003	0.997	0.000
F42 Obsessive-compulsive disorder	0.003	0.997	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.997	0.003
F48 Other neurotic disorders	0.003	0.997	0.000
F11.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F11.8 Other mental and behavioural disorders	0.003	0.997	0.000
F11.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F11.6 Amnesic syndrome	0.003	0.997	0.000
F11.5 Psychotic disorder	0.003	0.997	0.000
F11.4 Withdrawal state with delirium	0.003	0.997	0.000
F11.3 Withdrawal state	0.003	0.997	0.000
F11.0 Acute intoxication	0.003	0.997	0.000
B37.6 Candidal endocarditis	0.003	0.997	0.000
B37.5 Candidal meningitis	0.003	0.997	0.000
F43 Reaction to severe stress, and adjustment disorders	0.003	0.997	0.000
F43.0 Acute stress reaction	0.003	0.997	0.000
K66.0 Peritoneal adhesions	0.003	0.997	0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.003	0.997	0.000
F95 Tic disorders	0.003	0.997	0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence	0.003	0.997	0.000
F93 Emotional disorders with onset specific to childhood	0.003	0.997	0.000
F92 Mixed disorders of conduct and emotions	0.003	0.997	0.000
F91 Conduct disorders	0.003	0.997	0.000
F90 Hyperkinetic disorders	0.003	0.997	0.000
F78 Other mental retardation	0.003	0.997	0.000
F73 Profound mental retardation	0.003	0.997	0.000
F72 Severe mental retardation	0.003	0.997	0.000
F71 Moderate mental retardation	0.003	0.997	0.000
F70 Mild mental retardation	0.003	0.997	0.000
B37.9 Candidiasis, unspecified	0.003	0.997	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.997	0.003
F07.0 Organic personality disorder	0.003	0.997	0.000
F25 Schizoaffective disorders	0.003	0.997	0.000
F79 Unspecified mental retardation	0.003	0.997	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.003	0.997	0.000
C71.3 Parietal lobe	0.000	0.997	0.003
C71.0 Cerebrum, except lobes and ventricles	0.000	0.997	0.003
F80 Specific developmental disorders of speech and language	0.003	0.997	0.000
C71.2 Temporal lobe	0.000	0.997	0.003
N85.0 Endometrial glandular hyperplasia	0.003	0.997	0.000
F19.2 Dependence syndrome	0.003	0.997	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.003	0.997	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.003	0.997	0.000
F89 Unspecified disorder of psychological development	0.003	0.997	0.000
F88 Other disorders of psychological development	0.003	0.997	0.000
F83 Mixed specific developmental disorders	0.003	0.997	0.000
F82 Specific developmental disorder of motor function	0.003	0.997	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.003	0.997	0.000
F84 Pervasive developmental disorders	0.003	0.997	0.000
F02.0 Dementia in Pick's disease	0.003	0.997	0.000
H42 Glaucoma in diseases classified elsewhere	0.000	0.997	0.003
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.003	0.997	0.000
F02.3 Dementia in Parkinson's disease	0.003	0.997	0.000
F02.2 Dementia in Huntington's disease	0.003	0.997	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.003	0.997	0.000
F19.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F19.8 Other mental and behavioural disorders	0.003	0.997	0.000
F19.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F19.6 Amnesic syndrome	0.003	0.997	0.000
F19.5 Psychotic disorder	0.003	0.997	0.000
F19.4 Withdrawal state with delirium	0.003	0.997	0.000
F19.3 Withdrawal state	0.003	0.997	0.000
F19.0 Acute intoxication	0.003	0.997	0.000
B36 Other superficial mycoses	0.003	0.997	0.000
F13.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F13.8 Other mental and behavioural disorders	0.003	0.997	0.000
F13.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F13.6 Amnesic syndrome	0.003	0.997	0.000
F13.5 Psychotic disorder	0.003	0.997	0.000
F13.4 Withdrawal state with delirium	0.003	0.997	0.000
F13.3 Withdrawal state	0.003	0.997	0.000
F13.2 Dependence syndrome	0.003	0.997	0.000
F13.1 Harmful use	0.003	0.997	0.000
F13.0 Acute intoxication	0.003	0.997	0.000
F14.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F14.8 Other mental and behavioural disorders	0.003	0.997	0.000
F14.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F14.6 Amnesic syndrome	0.003	0.997	0.000
F14.5 Psychotic disorder	0.003	0.997	0.000
F14.4 Withdrawal state with delirium	0.003	0.997	0.000
F14.3 Withdrawal state	0.003	0.997	0.000
F14.2 Dependence syndrome	0.003	0.997	0.000
F14.1 Harmful use	0.003	0.997	0.000
F14.0 Acute intoxication	0.003	0.997	0.000
F16.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F16.8 Other mental and behavioural disorders	0.003	0.997	0.000
F16.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F16.6 Amnesic syndrome	0.003	0.997	0.000
F16.5 Psychotic disorder	0.003	0.997	0.000
F16.4 Withdrawal state with delirium	0.003	0.997	0.000
F16.3 Withdrawal state	0.003	0.997	0.000
F16.2 Dependence syndrome	0.003	0.997	0.000
F16.1 Harmful use	0.003	0.997	0.000
F16.0 Acute intoxication	0.003	0.997	0.000
F18.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F18.8 Other mental and behavioural disorders	0.003	0.997	0.000
F18.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F18.6 Amnesic syndrome	0.003	0.997	0.000
F18.5 Psychotic disorder	0.003	0.997	0.000
F18.4 Withdrawal state with delirium	0.003	0.997	0.000
F18.3 Withdrawal state	0.003	0.997	0.000
F18.2 Dependence syndrome	0.003	0.997	0.000
F18.1 Harmful use	0.003	0.997	0.000
F18.0 Acute intoxication	0.003	0.997	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.003	0.997	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.003	0.997	0.000
F07.1 Postencephalitic syndrome	0.003	0.997	0.000
F15.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F15.8 Other mental and behavioural disorders	0.003	0.997	0.000
F15.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F15.6 Amnesic syndrome	0.003	0.997	0.000
F15.5 Psychotic disorder	0.003	0.997	0.000
F15.4 Withdrawal state with delirium	0.003	0.997	0.000
F15.3 Withdrawal state	0.003	0.997	0.000
F15.2 Dependence syndrome	0.003	0.997	0.000
F15.0 Acute intoxication	0.003	0.997	0.000
F15.1 Harmful use	0.003	0.997	0.000
F42.9 Obsessive-compulsive disorder, unspecified	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations